FOLFIRINOX Improves PFS Compared with Gemcitabine in Patients with Locally Advanced Pancreatic Carcinoma By Ogkologos - May 26, 2025 493 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PRODIGE 29-UCGI 26 (NEOPAN) study Source RELATED ARTICLESMORE FROM AUTHOR Induction ICI Combination Followed by CRT Is An Effective Bladder-Sparing Treatment in Patients with MIBC and Response Can Be Monitored by ctDNA New Survey Highlights the Role of Clinical Practice Guidelines to Improve Care for Patients with Rare Cancers FDA Grants Traditional Approval to Encorafenib for mCRC with a BRAF V600E Mutation MOST POPULAR New drug available for rare thyroid cancer on NHS in England October 1, 2021 Death Rates from Lung Cancer will Fall Overall in the EU... March 6, 2023 Teen Helps Mom With Cancer Shave Her Head, Then Turns To... October 1, 2021 2021/22 in review: Charity looks to the future with ambitious new... July 21, 2022 Load more HOT NEWS Do Frequent Follow-Up Tests Benefit Colorectal Cancer Survivors? 7 Steps for Developing Microhabits During Cancer That Can Improve Your... New Research in Treating Leukemia and Lymphoma: ASH Annual Meeting 2020 Νέα διαγνωστική μέθοδος για τον καρκίνο, με τη συμβολή της Microsoft
